<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>This year in Galveston, Texas, Silvia Pierangeli hosts the 13th International Congress on <z:hpo ids='HP_0003613'>Antiphospholipid Antibodies</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Twenty-six years after the first <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> meeting, the number of interested colleagues has multiplied, and the subject has become more scientifically understood </plain></SENT>
<SENT sid="2" pm="."><plain>So also has the clinical picture </plain></SENT>
<SENT sid="3" pm="."><plain>In this short contribution, I will highlight a number of clinical observations which may, or may not, contribute to our understanding of <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
</text></document>